National charity Group B Strep Support and leading law firm Wolferstans are delighted to announce their new corporate partnership to raise greater awareness of group B Strep, and provide support to families affected by it.
Group B Strep is the most common cause of life-threatening infection in newborn babies, causing meningitis, sepsis or pneumonia in over 700 babies every year in the UK.
On average in the UK:
- two babies every day develop group B Strep infection
- one baby a week dies from group B Strep infection, and
- one baby a week survives their group B Strep infection with a fortnight is left with long-term disability
“We are delighted to be working with Group B Strep Support and supporting their vital campaign in ensuring that families , expectant mothers and health professionals have important information about Group B Strep.
Sadly, through our work we are all too familiar with the devastating consequences that undiagnosed and untreated Group B Strep can have on babies and their families. We hope that by working with Group B Strep Support we will be able to not only help those who have been affected by GBS but also promote knowledge and awareness to reduce the number of families affected.”
“We are very pleased to partner with Wolferstans who, with their experience of working with neonatal group B Strep cases, understand the importance of families and their health professionals having good quality information about group B Strep.”
She added: “By partnering with Wolferstans, we can provide information and support to families and their health professionals. We rely on partnerships like these to continue our vital work, and this new partnership will enable us to reach many more of the 800,000 families who have babies each year.”